Global mRNA COVID-19 Vaccine Market Growth 2026-2032
The global mRNA COVID-19 Vaccine market size is predicted to grow from US$ 4105 million in 2025 to US$ 4501 million in 2032; it is expected to grow at a CAGR of 1.3% from 2026 to 2032.
Messenger ribonucleic acid (mRNA) is a molecule that provides cells with instructions for making proteins. mRNA vaccines contain the instructions for making the SARS-CoV-2 spike protein. This protein is found on the surface of the virus that causes COVID-19. The mRNA molecule is essentially a recipe, telling the cells of the body how to make the spike protein. mRNA COVID-19 Vaccines are given by injection, usually into the muscle of the upper arm.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?mRNA COVID-19 Vaccine Industry Forecast? looks at past sales and reviews total world mRNA COVID-19 Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected mRNA COVID-19 Vaccine sales for 2026 through 2032. With mRNA COVID-19 Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA COVID-19 Vaccine industry.
This Insight Report provides a comprehensive analysis of the global mRNA COVID-19 Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA COVID-19 Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global mRNA COVID-19 Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA COVID-19 Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA COVID-19 Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA COVID-19 Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Messenger ribonucleic acid (mRNA) is a molecule that provides cells with instructions for making proteins. mRNA vaccines contain the instructions for making the SARS-CoV-2 spike protein. This protein is found on the surface of the virus that causes COVID-19. The mRNA molecule is essentially a recipe, telling the cells of the body how to make the spike protein. mRNA COVID-19 Vaccines are given by injection, usually into the muscle of the upper arm.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?mRNA COVID-19 Vaccine Industry Forecast? looks at past sales and reviews total world mRNA COVID-19 Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected mRNA COVID-19 Vaccine sales for 2026 through 2032. With mRNA COVID-19 Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA COVID-19 Vaccine industry.
This Insight Report provides a comprehensive analysis of the global mRNA COVID-19 Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA COVID-19 Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global mRNA COVID-19 Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA COVID-19 Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA COVID-19 Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA COVID-19 Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Non-replicating mRNA Vaccine
- Self-amplifying mRNA Vaccine
- Children
- Adults
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Moderna
- CanSino Biologicals
- Pfizer
- Fosun-Pharmaceutical
- CSPC Pharmaceutical
- What is the 10-year outlook for the global mRNA COVID-19 Vaccine market?
- What factors are driving mRNA COVID-19 Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do mRNA COVID-19 Vaccine market opportunities vary by end market size?
- How does mRNA COVID-19 Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA COVID-19 Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for mRNA COVID-19 Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for mRNA COVID-19 Vaccine by Country/Region, 2021, 2025 & 2032
2.2 mRNA COVID-19 Vaccine Segment by Type
2.2.1 Non-replicating mRNA Vaccine
2.2.2 Self-amplifying mRNA Vaccine
2.2.3 mRNA COVID-19 Vaccine Sales by Type
2.2.3.1 Global mRNA COVID-19 Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global mRNA COVID-19 Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global mRNA COVID-19 Vaccine Sale Price by Type (2021-2026)
2.3 mRNA COVID-19 Vaccine Segment by Application
2.3.1 Children
2.3.2 Adults
2.3.3 mRNA COVID-19 Vaccine Sales by Application
2.3.3.1 Global mRNA COVID-19 Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global mRNA COVID-19 Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global mRNA COVID-19 Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global mRNA COVID-19 Vaccine Breakdown Data by Company
3.1.1 Global mRNA COVID-19 Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global mRNA COVID-19 Vaccine Sales Market Share by Company (2021-2026)
3.2 Global mRNA COVID-19 Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global mRNA COVID-19 Vaccine Revenue by Company (2021-2026)
3.2.2 Global mRNA COVID-19 Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global mRNA COVID-19 Vaccine Sale Price by Company
3.4 Key Manufacturers mRNA COVID-19 Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers mRNA COVID-19 Vaccine Product Location Distribution
3.4.2 Players mRNA COVID-19 Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MRNA COVID-19 VACCINE BY GEOGRAPHIC REGION
4.1 World Historic mRNA COVID-19 Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global mRNA COVID-19 Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global mRNA COVID-19 Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic mRNA COVID-19 Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global mRNA COVID-19 Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global mRNA COVID-19 Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas mRNA COVID-19 Vaccine Sales Growth
4.4 APAC mRNA COVID-19 Vaccine Sales Growth
4.5 Europe mRNA COVID-19 Vaccine Sales Growth
4.6 Middle East & Africa mRNA COVID-19 Vaccine Sales Growth
5 AMERICAS
5.1 Americas mRNA COVID-19 Vaccine Sales by Country
5.1.1 Americas mRNA COVID-19 Vaccine Sales by Country (2021-2026)
5.1.2 Americas mRNA COVID-19 Vaccine Revenue by Country (2021-2026)
5.2 Americas mRNA COVID-19 Vaccine Sales by Type (2021-2026)
5.3 Americas mRNA COVID-19 Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA COVID-19 Vaccine Sales by Region
6.1.1 APAC mRNA COVID-19 Vaccine Sales by Region (2021-2026)
6.1.2 APAC mRNA COVID-19 Vaccine Revenue by Region (2021-2026)
6.2 APAC mRNA COVID-19 Vaccine Sales by Type (2021-2026)
6.3 APAC mRNA COVID-19 Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe mRNA COVID-19 Vaccine by Country
7.1.1 Europe mRNA COVID-19 Vaccine Sales by Country (2021-2026)
7.1.2 Europe mRNA COVID-19 Vaccine Revenue by Country (2021-2026)
7.2 Europe mRNA COVID-19 Vaccine Sales by Type (2021-2026)
7.3 Europe mRNA COVID-19 Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA COVID-19 Vaccine by Country
8.1.1 Middle East & Africa mRNA COVID-19 Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa mRNA COVID-19 Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa mRNA COVID-19 Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa mRNA COVID-19 Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of mRNA COVID-19 Vaccine
10.3 Manufacturing Process Analysis of mRNA COVID-19 Vaccine
10.4 Industry Chain Structure of mRNA COVID-19 Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 mRNA COVID-19 Vaccine Distributors
11.3 mRNA COVID-19 Vaccine Customer
12 WORLD FORECAST REVIEW FOR MRNA COVID-19 VACCINE BY GEOGRAPHIC REGION
12.1 Global mRNA COVID-19 Vaccine Market Size Forecast by Region
12.1.1 Global mRNA COVID-19 Vaccine Forecast by Region (2027-2032)
12.1.2 Global mRNA COVID-19 Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global mRNA COVID-19 Vaccine Forecast by Type (2027-2032)
12.7 Global mRNA COVID-19 Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Moderna
13.1.1 Moderna Company Information
13.1.2 Moderna mRNA COVID-19 Vaccine Product Portfolios and Specifications
13.1.3 Moderna mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Moderna Main Business Overview
13.1.5 Moderna Latest Developments
13.2 CanSino Biologicals
13.2.1 CanSino Biologicals Company Information
13.2.2 CanSino Biologicals mRNA COVID-19 Vaccine Product Portfolios and Specifications
13.2.3 CanSino Biologicals mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CanSino Biologicals Main Business Overview
13.2.5 CanSino Biologicals Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer mRNA COVID-19 Vaccine Product Portfolios and Specifications
13.3.3 Pfizer mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Fosun-Pharmaceutical
13.4.1 Fosun-Pharmaceutical Company Information
13.4.2 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product Portfolios and Specifications
13.4.3 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Fosun-Pharmaceutical Main Business Overview
13.4.5 Fosun-Pharmaceutical Latest Developments
13.5 CSPC Pharmaceutical
13.5.1 CSPC Pharmaceutical Company Information
13.5.2 CSPC Pharmaceutical mRNA COVID-19 Vaccine Product Portfolios and Specifications
13.5.3 CSPC Pharmaceutical mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 CSPC Pharmaceutical Main Business Overview
13.5.5 CSPC Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA COVID-19 Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for mRNA COVID-19 Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for mRNA COVID-19 Vaccine by Country/Region, 2021, 2025 & 2032
2.2 mRNA COVID-19 Vaccine Segment by Type
2.2.1 Non-replicating mRNA Vaccine
2.2.2 Self-amplifying mRNA Vaccine
2.2.3 mRNA COVID-19 Vaccine Sales by Type
2.2.3.1 Global mRNA COVID-19 Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global mRNA COVID-19 Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global mRNA COVID-19 Vaccine Sale Price by Type (2021-2026)
2.3 mRNA COVID-19 Vaccine Segment by Application
2.3.1 Children
2.3.2 Adults
2.3.3 mRNA COVID-19 Vaccine Sales by Application
2.3.3.1 Global mRNA COVID-19 Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global mRNA COVID-19 Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global mRNA COVID-19 Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global mRNA COVID-19 Vaccine Breakdown Data by Company
3.1.1 Global mRNA COVID-19 Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global mRNA COVID-19 Vaccine Sales Market Share by Company (2021-2026)
3.2 Global mRNA COVID-19 Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global mRNA COVID-19 Vaccine Revenue by Company (2021-2026)
3.2.2 Global mRNA COVID-19 Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global mRNA COVID-19 Vaccine Sale Price by Company
3.4 Key Manufacturers mRNA COVID-19 Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers mRNA COVID-19 Vaccine Product Location Distribution
3.4.2 Players mRNA COVID-19 Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MRNA COVID-19 VACCINE BY GEOGRAPHIC REGION
4.1 World Historic mRNA COVID-19 Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global mRNA COVID-19 Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global mRNA COVID-19 Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic mRNA COVID-19 Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global mRNA COVID-19 Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global mRNA COVID-19 Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas mRNA COVID-19 Vaccine Sales Growth
4.4 APAC mRNA COVID-19 Vaccine Sales Growth
4.5 Europe mRNA COVID-19 Vaccine Sales Growth
4.6 Middle East & Africa mRNA COVID-19 Vaccine Sales Growth
5 AMERICAS
5.1 Americas mRNA COVID-19 Vaccine Sales by Country
5.1.1 Americas mRNA COVID-19 Vaccine Sales by Country (2021-2026)
5.1.2 Americas mRNA COVID-19 Vaccine Revenue by Country (2021-2026)
5.2 Americas mRNA COVID-19 Vaccine Sales by Type (2021-2026)
5.3 Americas mRNA COVID-19 Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA COVID-19 Vaccine Sales by Region
6.1.1 APAC mRNA COVID-19 Vaccine Sales by Region (2021-2026)
6.1.2 APAC mRNA COVID-19 Vaccine Revenue by Region (2021-2026)
6.2 APAC mRNA COVID-19 Vaccine Sales by Type (2021-2026)
6.3 APAC mRNA COVID-19 Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe mRNA COVID-19 Vaccine by Country
7.1.1 Europe mRNA COVID-19 Vaccine Sales by Country (2021-2026)
7.1.2 Europe mRNA COVID-19 Vaccine Revenue by Country (2021-2026)
7.2 Europe mRNA COVID-19 Vaccine Sales by Type (2021-2026)
7.3 Europe mRNA COVID-19 Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA COVID-19 Vaccine by Country
8.1.1 Middle East & Africa mRNA COVID-19 Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa mRNA COVID-19 Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa mRNA COVID-19 Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa mRNA COVID-19 Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of mRNA COVID-19 Vaccine
10.3 Manufacturing Process Analysis of mRNA COVID-19 Vaccine
10.4 Industry Chain Structure of mRNA COVID-19 Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 mRNA COVID-19 Vaccine Distributors
11.3 mRNA COVID-19 Vaccine Customer
12 WORLD FORECAST REVIEW FOR MRNA COVID-19 VACCINE BY GEOGRAPHIC REGION
12.1 Global mRNA COVID-19 Vaccine Market Size Forecast by Region
12.1.1 Global mRNA COVID-19 Vaccine Forecast by Region (2027-2032)
12.1.2 Global mRNA COVID-19 Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global mRNA COVID-19 Vaccine Forecast by Type (2027-2032)
12.7 Global mRNA COVID-19 Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Moderna
13.1.1 Moderna Company Information
13.1.2 Moderna mRNA COVID-19 Vaccine Product Portfolios and Specifications
13.1.3 Moderna mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Moderna Main Business Overview
13.1.5 Moderna Latest Developments
13.2 CanSino Biologicals
13.2.1 CanSino Biologicals Company Information
13.2.2 CanSino Biologicals mRNA COVID-19 Vaccine Product Portfolios and Specifications
13.2.3 CanSino Biologicals mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CanSino Biologicals Main Business Overview
13.2.5 CanSino Biologicals Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer mRNA COVID-19 Vaccine Product Portfolios and Specifications
13.3.3 Pfizer mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Fosun-Pharmaceutical
13.4.1 Fosun-Pharmaceutical Company Information
13.4.2 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product Portfolios and Specifications
13.4.3 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Fosun-Pharmaceutical Main Business Overview
13.4.5 Fosun-Pharmaceutical Latest Developments
13.5 CSPC Pharmaceutical
13.5.1 CSPC Pharmaceutical Company Information
13.5.2 CSPC Pharmaceutical mRNA COVID-19 Vaccine Product Portfolios and Specifications
13.5.3 CSPC Pharmaceutical mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 CSPC Pharmaceutical Main Business Overview
13.5.5 CSPC Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. mRNA COVID-19 Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. mRNA COVID-19 Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Non-replicating mRNA Vaccine
Table 4. Major Players of Self-amplifying mRNA Vaccine
Table 5. Global mRNA COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global mRNA COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global mRNA COVID-19 Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global mRNA COVID-19 Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global mRNA COVID-19 Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global mRNA COVID-19 Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global mRNA COVID-19 Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global mRNA COVID-19 Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global mRNA COVID-19 Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global mRNA COVID-19 Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global mRNA COVID-19 Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global mRNA COVID-19 Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global mRNA COVID-19 Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global mRNA COVID-19 Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global mRNA COVID-19 Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers mRNA COVID-19 Vaccine Producing Area Distribution and Sales Area
Table 21. Players mRNA COVID-19 Vaccine Products Offered
Table 22. mRNA COVID-19 Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global mRNA COVID-19 Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global mRNA COVID-19 Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global mRNA COVID-19 Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global mRNA COVID-19 Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global mRNA COVID-19 Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global mRNA COVID-19 Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global mRNA COVID-19 Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global mRNA COVID-19 Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas mRNA COVID-19 Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas mRNA COVID-19 Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas mRNA COVID-19 Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas mRNA COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas mRNA COVID-19 Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC mRNA COVID-19 Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC mRNA COVID-19 Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC mRNA COVID-19 Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC mRNA COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC mRNA COVID-19 Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe mRNA COVID-19 Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe mRNA COVID-19 Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe mRNA COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe mRNA COVID-19 Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa mRNA COVID-19 Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa mRNA COVID-19 Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa mRNA COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa mRNA COVID-19 Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of mRNA COVID-19 Vaccine
Table 52. Key Market Challenges & Risks of mRNA COVID-19 Vaccine
Table 53. Key Industry Trends of mRNA COVID-19 Vaccine
Table 54. mRNA COVID-19 Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. mRNA COVID-19 Vaccine Distributors List
Table 57. mRNA COVID-19 Vaccine Customer List
Table 58. Global mRNA COVID-19 Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global mRNA COVID-19 Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas mRNA COVID-19 Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas mRNA COVID-19 Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC mRNA COVID-19 Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC mRNA COVID-19 Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe mRNA COVID-19 Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe mRNA COVID-19 Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa mRNA COVID-19 Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa mRNA COVID-19 Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global mRNA COVID-19 Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global mRNA COVID-19 Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global mRNA COVID-19 Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global mRNA COVID-19 Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Moderna Basic Information, mRNA COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Moderna mRNA COVID-19 Vaccine Product Portfolios and Specifications
Table 74. Moderna mRNA COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Moderna Main Business
Table 76. Moderna Latest Developments
Table 77. CanSino Biologicals Basic Information, mRNA COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. CanSino Biologicals mRNA COVID-19 Vaccine Product Portfolios and Specifications
Table 79. CanSino Biologicals mRNA COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. CanSino Biologicals Main Business
Table 81. CanSino Biologicals Latest Developments
Table 82. Pfizer Basic Information, mRNA COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Pfizer mRNA COVID-19 Vaccine Product Portfolios and Specifications
Table 84. Pfizer mRNA COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Pfizer Main Business
Table 86. Pfizer Latest Developments
Table 87. Fosun-Pharmaceutical Basic Information, mRNA COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product Portfolios and Specifications
Table 89. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Fosun-Pharmaceutical Main Business
Table 91. Fosun-Pharmaceutical Latest Developments
Table 92. CSPC Pharmaceutical Basic Information, mRNA COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. CSPC Pharmaceutical mRNA COVID-19 Vaccine Product Portfolios and Specifications
Table 94. CSPC Pharmaceutical mRNA COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. CSPC Pharmaceutical Main Business
Table 96. CSPC Pharmaceutical Latest Developments
Table 1. mRNA COVID-19 Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. mRNA COVID-19 Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Non-replicating mRNA Vaccine
Table 4. Major Players of Self-amplifying mRNA Vaccine
Table 5. Global mRNA COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global mRNA COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global mRNA COVID-19 Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global mRNA COVID-19 Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global mRNA COVID-19 Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global mRNA COVID-19 Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global mRNA COVID-19 Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global mRNA COVID-19 Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global mRNA COVID-19 Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global mRNA COVID-19 Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global mRNA COVID-19 Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global mRNA COVID-19 Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global mRNA COVID-19 Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global mRNA COVID-19 Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global mRNA COVID-19 Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers mRNA COVID-19 Vaccine Producing Area Distribution and Sales Area
Table 21. Players mRNA COVID-19 Vaccine Products Offered
Table 22. mRNA COVID-19 Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global mRNA COVID-19 Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global mRNA COVID-19 Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global mRNA COVID-19 Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global mRNA COVID-19 Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global mRNA COVID-19 Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global mRNA COVID-19 Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global mRNA COVID-19 Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global mRNA COVID-19 Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas mRNA COVID-19 Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas mRNA COVID-19 Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas mRNA COVID-19 Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas mRNA COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas mRNA COVID-19 Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC mRNA COVID-19 Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC mRNA COVID-19 Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC mRNA COVID-19 Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC mRNA COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC mRNA COVID-19 Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe mRNA COVID-19 Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe mRNA COVID-19 Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe mRNA COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe mRNA COVID-19 Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa mRNA COVID-19 Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa mRNA COVID-19 Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa mRNA COVID-19 Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa mRNA COVID-19 Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of mRNA COVID-19 Vaccine
Table 52. Key Market Challenges & Risks of mRNA COVID-19 Vaccine
Table 53. Key Industry Trends of mRNA COVID-19 Vaccine
Table 54. mRNA COVID-19 Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. mRNA COVID-19 Vaccine Distributors List
Table 57. mRNA COVID-19 Vaccine Customer List
Table 58. Global mRNA COVID-19 Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global mRNA COVID-19 Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas mRNA COVID-19 Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas mRNA COVID-19 Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC mRNA COVID-19 Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC mRNA COVID-19 Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe mRNA COVID-19 Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe mRNA COVID-19 Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa mRNA COVID-19 Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa mRNA COVID-19 Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global mRNA COVID-19 Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global mRNA COVID-19 Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global mRNA COVID-19 Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global mRNA COVID-19 Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Moderna Basic Information, mRNA COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Moderna mRNA COVID-19 Vaccine Product Portfolios and Specifications
Table 74. Moderna mRNA COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Moderna Main Business
Table 76. Moderna Latest Developments
Table 77. CanSino Biologicals Basic Information, mRNA COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. CanSino Biologicals mRNA COVID-19 Vaccine Product Portfolios and Specifications
Table 79. CanSino Biologicals mRNA COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. CanSino Biologicals Main Business
Table 81. CanSino Biologicals Latest Developments
Table 82. Pfizer Basic Information, mRNA COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Pfizer mRNA COVID-19 Vaccine Product Portfolios and Specifications
Table 84. Pfizer mRNA COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Pfizer Main Business
Table 86. Pfizer Latest Developments
Table 87. Fosun-Pharmaceutical Basic Information, mRNA COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product Portfolios and Specifications
Table 89. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Fosun-Pharmaceutical Main Business
Table 91. Fosun-Pharmaceutical Latest Developments
Table 92. CSPC Pharmaceutical Basic Information, mRNA COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. CSPC Pharmaceutical mRNA COVID-19 Vaccine Product Portfolios and Specifications
Table 94. CSPC Pharmaceutical mRNA COVID-19 Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. CSPC Pharmaceutical Main Business
Table 96. CSPC Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of mRNA COVID-19 Vaccine
Figure 2. mRNA COVID-19 Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global mRNA COVID-19 Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global mRNA COVID-19 Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. mRNA COVID-19 Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. mRNA COVID-19 Vaccine Sales Market Share by Country/Region (2025)
Figure 10. mRNA COVID-19 Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Non-replicating mRNA Vaccine
Figure 12. Product Picture of Self-amplifying mRNA Vaccine
Figure 13. Global mRNA COVID-19 Vaccine Sales Market Share by Type in 2026
Figure 14. Global mRNA COVID-19 Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. mRNA COVID-19 Vaccine Consumed in Children
Figure 16. Global mRNA COVID-19 Vaccine Market: Children (2021-2026) & (K Units)
Figure 17. mRNA COVID-19 Vaccine Consumed in Adults
Figure 18. Global mRNA COVID-19 Vaccine Market: Adults (2021-2026) & (K Units)
Figure 19. Global mRNA COVID-19 Vaccine Sale Market Share by Application (2025)
Figure 20. Global mRNA COVID-19 Vaccine Revenue Market Share by Application in 2026
Figure 21. mRNA COVID-19 Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global mRNA COVID-19 Vaccine Sales Market Share by Company in 2026
Figure 23. mRNA COVID-19 Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global mRNA COVID-19 Vaccine Revenue Market Share by Company in 2026
Figure 25. Global mRNA COVID-19 Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global mRNA COVID-19 Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas mRNA COVID-19 Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas mRNA COVID-19 Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC mRNA COVID-19 Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC mRNA COVID-19 Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe mRNA COVID-19 Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe mRNA COVID-19 Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa mRNA COVID-19 Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa mRNA COVID-19 Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas mRNA COVID-19 Vaccine Sales Market Share by Country in 2026
Figure 36. Americas mRNA COVID-19 Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas mRNA COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas mRNA COVID-19 Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC mRNA COVID-19 Vaccine Sales Market Share by Region in 2026
Figure 44. APAC mRNA COVID-19 Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC mRNA COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC mRNA COVID-19 Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe mRNA COVID-19 Vaccine Sales Market Share by Country in 2026
Figure 55. Europe mRNA COVID-19 Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe mRNA COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe mRNA COVID-19 Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa mRNA COVID-19 Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa mRNA COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa mRNA COVID-19 Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of mRNA COVID-19 Vaccine in 2026
Figure 72. Manufacturing Process Analysis of mRNA COVID-19 Vaccine
Figure 73. Industry Chain Structure of mRNA COVID-19 Vaccine
Figure 74. Channels of Distribution
Figure 75. Global mRNA COVID-19 Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global mRNA COVID-19 Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global mRNA COVID-19 Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global mRNA COVID-19 Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global mRNA COVID-19 Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global mRNA COVID-19 Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of mRNA COVID-19 Vaccine
Figure 2. mRNA COVID-19 Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global mRNA COVID-19 Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global mRNA COVID-19 Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. mRNA COVID-19 Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. mRNA COVID-19 Vaccine Sales Market Share by Country/Region (2025)
Figure 10. mRNA COVID-19 Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Non-replicating mRNA Vaccine
Figure 12. Product Picture of Self-amplifying mRNA Vaccine
Figure 13. Global mRNA COVID-19 Vaccine Sales Market Share by Type in 2026
Figure 14. Global mRNA COVID-19 Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. mRNA COVID-19 Vaccine Consumed in Children
Figure 16. Global mRNA COVID-19 Vaccine Market: Children (2021-2026) & (K Units)
Figure 17. mRNA COVID-19 Vaccine Consumed in Adults
Figure 18. Global mRNA COVID-19 Vaccine Market: Adults (2021-2026) & (K Units)
Figure 19. Global mRNA COVID-19 Vaccine Sale Market Share by Application (2025)
Figure 20. Global mRNA COVID-19 Vaccine Revenue Market Share by Application in 2026
Figure 21. mRNA COVID-19 Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global mRNA COVID-19 Vaccine Sales Market Share by Company in 2026
Figure 23. mRNA COVID-19 Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global mRNA COVID-19 Vaccine Revenue Market Share by Company in 2026
Figure 25. Global mRNA COVID-19 Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global mRNA COVID-19 Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas mRNA COVID-19 Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas mRNA COVID-19 Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC mRNA COVID-19 Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC mRNA COVID-19 Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe mRNA COVID-19 Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe mRNA COVID-19 Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa mRNA COVID-19 Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa mRNA COVID-19 Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas mRNA COVID-19 Vaccine Sales Market Share by Country in 2026
Figure 36. Americas mRNA COVID-19 Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas mRNA COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas mRNA COVID-19 Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC mRNA COVID-19 Vaccine Sales Market Share by Region in 2026
Figure 44. APAC mRNA COVID-19 Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC mRNA COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC mRNA COVID-19 Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe mRNA COVID-19 Vaccine Sales Market Share by Country in 2026
Figure 55. Europe mRNA COVID-19 Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe mRNA COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe mRNA COVID-19 Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa mRNA COVID-19 Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa mRNA COVID-19 Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa mRNA COVID-19 Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries mRNA COVID-19 Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of mRNA COVID-19 Vaccine in 2026
Figure 72. Manufacturing Process Analysis of mRNA COVID-19 Vaccine
Figure 73. Industry Chain Structure of mRNA COVID-19 Vaccine
Figure 74. Channels of Distribution
Figure 75. Global mRNA COVID-19 Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global mRNA COVID-19 Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global mRNA COVID-19 Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global mRNA COVID-19 Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global mRNA COVID-19 Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global mRNA COVID-19 Vaccine Revenue Market Share Forecast by Application (2027-2032)
